Morgan Research, the GLP-1 medication market covering both diabetes and obesity is projected to exceed $100 billion by 2030 though price cuts in the US
Kidney function, current blood sugar control, previous metformin exposure, gastrointestinal tolerance, and other glucose-lowering medicines influence how a clinician chooses and adjusts the dose
Human single-cell datasets in the same study align with this pattern
Commonly reported side effects include: Nausea and vomiting Diarrhea or constipation Decreased appetite In some cases, more serious health concerns have been reported, including: Gastroparesis (Stomach Paralysis) A condition where the stomach empties food very slowly or stops functioning properly, potentially causing severe nausea, vomiting, bloating, abdominal pain, and difficulty eating
Efficacy and Safety of Phentermine/Topiramate in Adults With Overweight or Obesity: A Systematic Review and MetaAnalysis
This makes it a valuable option for those struggling with weight-related health issues who are looking to improve their overall body composition
